Patents by Inventor John F. Bruno

John F. Bruno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170212114
    Abstract: Novel Borrelia burgdorferi recombinant proteins and methods of assessing a sample for the presence of antibodies to certain proteins of Borrelia burgdorferi, are described, as are methods of diagnosing Lyme disease. Microarrays of proteins of Borrelia burgdorferi are also described.
    Type: Application
    Filed: April 6, 2017
    Publication date: July 27, 2017
    Inventors: Benjamin J. Luft, John F. Bruno, Yun Xu
  • Publication number: 20110105355
    Abstract: Methods of assessing a sample for the presence of antibodies to cell envelope proteins of Borrelia burgdorferi, are described, as are methods of diagnosing Lyme disease. Microarrays of cell envelope proteins of Borrelia burgdorferi are also described.
    Type: Application
    Filed: April 21, 2009
    Publication date: May 5, 2011
    Applicant: RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    Inventors: Benjamin J. Luft, Yun Xu, John F. Bruno
  • Publication number: 20100292096
    Abstract: Methods of assessing a sample for the presence of antibodies to certain proteins of Borrelia burgdorferi, are described, as are methods of diagnosing Lyme disease. Microarrays of proteins of Borrelia burgdorferi are also described.
    Type: Application
    Filed: May 21, 2010
    Publication date: November 18, 2010
    Applicant: Research Foundation of State University of New York
    Inventors: Benjamin J. Luft, John F. Bruno, Yun Xu
  • Patent number: 6013622
    Abstract: Methods and compositions capable of controlling weight in an animal, preferably a human, which methods involve administering diet compositions that modulate, and preferably reduce, synthesis and secretion of neuropeptide Y (NPY) and modulate, and preferably increase synthesis and secretion of growth hormone releasing factor (GRF), compared to pre-administration amounts in the animal. The administration of such diet compositions results in a reduced appetite and a regulated metabolism that enhance weight control, including weight loss and reduction of obesity.
    Type: Grant
    Filed: April 15, 1998
    Date of Patent: January 11, 2000
    Assignees: Nutriceutical Technology Corporation, Research Foundation of State University of New York
    Inventors: John F. Bruno, Jeffrey White, Michael Berelowitz, Daniel Tripodi, Matthew Heil